4EG-16505-57870
3 vaccinations
7 coded responses
30 check-ins
7 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 902 / CA
- Registered
- 2021-02-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-03
Registered in v-safe
-
2021-02-03
Dose 1 — Pfizer-BioNTech
- 2021-02-03
-
2021-02-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-05
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling, Itching · Muscle or body achesAdult check-in
- 2021-02-06
-
2021-02-08
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Swelling · Headache, Muscle or body achesAdult check-in
- 2021-02-09
- 2021-02-10
-
2021-02-19
Survey response — day 14, dose 1MedDRA: Feeling abnormal, Oropharyngeal pain, Pyrexia — Feeling: GoodFree text: Sore throat, feverish, foggy memoryMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-24
Dose 2 — Pfizer-BioNTech
-
2021-02-24
Survey response — day 21, dose 1MedDRA: Dizziness, Headache — Feeling: Good · Be unable to do your normal daily activitiesFree text: Headaches, dizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling, Itching · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Itching · Chills, Headache, Fatigue or tirednessAdult check-in
-
2021-02-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Headache, Fatigue or tirednessAdult check-in
- 2021-03-01
- 2021-03-02
-
2021-03-03
Health check-in — day 7, dose 2Feeling: Poor · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-10
- 2021-03-17
-
2021-03-24
Survey response — day 28, dose 2MedDRA: Headache — Feeling: Good · Be unable to do your normal daily activitiesFree text: Frequent headachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-02
-
2021-04-07
Survey response — day 42, dose 2MedDRA: Nail discolouration, Swelling — Feeling: Good · Be unable to do your normal daily activitiesFree text: Swollen big toe on right foot, outer corner of nail. Bluish purple skin around swelling.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-26
-
2021-08-31
Survey response — 6 months, dose 2MedDRA: Migraine — Feeling: Good · Be unable to do your normal daily activitiesFree text: Frequent migraine headachesMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-11
Dose 3 — Pfizer-BioNTech
- 2021-09-29
- 2021-10-02
- 2021-10-09
- 2021-10-16
- 2021-10-23
-
2021-12-11
Survey response — 3 months, dose 3MedDRA: Extrasystoles, Obstructive airways disorder, Respiratory disorder — Feeling: Good · Be unable to do your normal daily activitiesFree text: Feeling of airway obstruction during resting periods. I feel as if an airway valve closes when I exhale and when I count my heartbeats while exhaling there seems to be a skip.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-13
Survey response — 12 months, dose 3MedDRA: Fatigue, Muscular weakness, Restlessness — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Weakness in legs and feet every morning. Overall fatigue after waking up. Restlessness before sleepingMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-03 | Pfizer-BioNTech | |
| 2 | 2021-02-24 | Pfizer-BioNTech | |
| 3 | 2021-09-11 | Pfizer-BioNTech | No |
Free text
Release 4 — day 14, dose 1
Symptoms: Sore throat, feverish, foggy memory
Release 4 — day 21, dose 1
Symptoms: Headaches, dizziness
Release 6 — day 28, dose 2
Symptoms: Frequent headaches
Release 7 — day 42, dose 2
Symptoms: Swollen big toe on right foot, outer corner of nail. Bluish purple skin around swelling.
Release 9 — 6 months, dose 2
Symptoms: Frequent migraine headaches
Release 10 — 3 months, dose 3
Symptoms: Feeling of airway obstruction during resting periods. I feel as if an airway valve closes when I exhale and when I count my heartbeats while exhaling there seems to be a skip.
Release 12 — 12 months, dose 3
Symptoms: Weakness in legs and feet every morning. Overall fatigue after waking up. Restlessness before sleeping
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Extrasystoles | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Feeling abnormal | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | · | ✓ |
| SD | Muscular weakness | · | · | ✓ |
| SD | Nail discolouration | ✓ | ✓ | ✓ |
| SD | Obstructive airways disorder | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Respiratory disorder | · | · | ✓ |
| SD | Restlessness | · | · | ✓ |
| SD | Swelling | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release